pamidronate has been researched along with Spondylarthropathies in 1 studies
Spondylarthropathies: Heterogeneous group of arthritic diseases sharing clinical and radiologic features. They are associated with the HLA-B27 ANTIGEN and some with a triggering infection. Most involve the axial joints in the SPINE, particularly the SACROILIAC JOINT, but can also involve asymmetric peripheral joints. Subsets include ANKYLOSING SPONDYLITIS; REACTIVE ARTHRITIS; PSORIATIC ARTHRITIS; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Undifferentiated spondyloarthropathy (uSpA) is a nonspecific form of spondyloarthropathy where nonsteroidal anti-inflammatory drugs (NSAIDs) and disease-modifying anti-rheumatic drugs are still mainstay of treatment." | 2.77 | Assessment of efficacy of pamidronate in undifferentiated spondyloarthropathy (uSpA): a placebo control trial in a tertiary level center. ( Bhattacharyya, K; De, D; Phaujdar, S; Sarkar, RN, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sarkar, RN | 1 |
| Phaujdar, S | 1 |
| De, D | 1 |
| Bhattacharyya, K | 1 |
1 trial available for pamidronate and Spondylarthropathies
| Article | Year |
|---|---|
Assessment of efficacy of pamidronate in undifferentiated spondyloarthropathy (uSpA): a placebo control trial in a tertiary level center.
Topics: Adult; Anti-Inflammatory Agents; Blood Sedimentation; Diphosphonates; Female; Humans; Male; Middle A | 2012 |